Mauro Ferrari Net Worth & Insider Trades
Mauro Ferrari - Director, Arrowhead Pharmaceuticals, Inc
What is Mauro Ferrari's Net Worth?
The current estimated net worth of Arrowhead Pharmaceuticals, Inc's Director, Mauro Ferrari, is estimated to be about $1.58M . Mauro Ferrari owns about 36,571 units of Arrowhead Pharmaceuticals, Inc common stock. In the last 8 years at Arrowhead Pharmaceuticals, Inc, Mauro Ferrari has sold an estimated value of $1.2M worth.
What is Mauro Ferrari's Past Insider Trading?
Mauro Ferrari's largest purchase order was 2,300 units , worth over $14.81K on January 14, 2015. Mauro Ferrari's largest sale order was 17,756 units , worth over $490.24K on June 28, 2019. In total, Mauro Ferrari has made about 13 transactions over 8 years of their time at Arrowhead Pharmaceuticals, Inc. Mauro Ferrari usually trades in January, with the busiest year in 2020. The most recent transaction was a sale order of 3,400 units , worth over $227.19K on December 29, 2021.
Mauro Ferrari
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Mauro Ferrari's' Mailing Address?
- Mailing address is 201 South Lake Avenue Pasadena CA 91101 CA
Arrowhead Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Christopher Anzalone | 2020 | $785,625 | - | $12,686,000 | - | $820,000 | $2,892 | $14,294,517 |
| Christopher Anzalone | 2019 | $674,375 | - | - | - | $1,540,000 | $1,889 | $2,216,264 |
| Christopher Anzalone | 2018 | $643,012 | - | - | - | $975,000 | $1,889 | $1,619,901 |
| Kenneth Myszkowski | 2020 | $463,750 | - | $5,391,550 | - | $213,750 | $12,802 | $6,081,852 |
| Kenneth Myszkowski | 2019 | $422,500 | - | $1,055,700 | - | $251,550 | $11,799 | $1,741,549 |
| Kenneth Myszkowski | 2018 | $384,841 | - | $276,000 | - | $180,000 | $12,177 | $853,018 |
| Javier San Martin | 2020 | $380,769 | $100,000 | $7,225,500 | - | $180,000 | $12,802 | $7,899,071 |
| Javier San Martin | 2019 | - | - | - | - | - | - | - |
| Javier San Martin | 2018 | - | - | - | - | - | - | - |
| James Hassard | 2020 | $302,404 | - | $7,430,000 | - | $170,000 | $15,892 | $7,918,296 |
| James Hassard | 2019 | - | - | - | - | - | - | - |
| James Hassard | 2018 | - | - | - | - | - | - | - |
| Curt Bradshaw | 2020 | $338,462 | - | $6,021,250 | - | - | $13,494 | $6,373,206 |
| Curt Bradshaw | 2019 | - | - | - | - | - | - | - |
| Curt Bradshaw | 2018 | - | - | - | - | - | - | - |
| Bruce D. Given | 2020 | $409,615 | - | $15,857,500 | - | - | $76,693 | $16,343,808 |
| Bruce D. Given | 2019 | $488,750 | - | $2,608,200 | - | $850,000 | $11,799 | $3,958,759 |
| Bruce D. Given | 2018 | $450,362 | - | $644,000 | - | $445,900 | $11,799 | $1,552,061 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/879407/000119312521019640/d76219ddef14a.htm
What are Arrowhead Pharmaceuticals, Inc's Past Insider Trades?
Arrowhead Pharmaceuticals, Inc's most recent insider trade came on May 8, 2023 by Douglass Given who sold 6,500 units worth $265.85K . In the last 19 years, insiders at Arrowhead Pharmaceuticals, Inc have sold an estimated value of $167.38M and bought an estimated value of $10.66M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are Christopher Anzalone, Chief Executive Officer, Kenneth Myszkowski, Chief Financial Officer, and Charles McKenney, Director .
ARROWHEAD PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||